IL1B and myeloid sarcoma: Inflammatory cytokines, such as Interleukin (IL)-1, IL-6, and IL-17, which are involved in the pathogenesis of many autoimmune diseases including MS, enhance differentiation and activation of osteoclasts, posing a possible indirect effect in bone loss mediated by RANKL.